Custom service
Peptides-Imaging Agents Conjugation
Label peptides with fluorophores, chelators or photosensitizers for imaging studies
The service is built around NIR fluorophore conjugation (IRDye, Cy5/Cy7 families). Depending on the molecule we may move to DOTA and NOTA chelator installation or photosensitizer coupling for photodynamic studies to improve stability, loading or yield, and every batch is released with labeled peptide with dye-to-peptide ratio certificate.
Because Peptides-Imaging Agents Conjugation projects usually feed a downstream assay or preclinical study, we lock the release specification early — purity, identity and functional readouts are agreed at quotation, not discovered at delivery.
In-vivo fluorescence imaging probes
PET/SPECT precursor development
Clinical-grade radiopharmaceutical release
Conjugates whose payload cannot tolerate aqueous coupling conditions
Every conjugation batch is documented from vial to vial: carrier lot, payload lot, reagent lots, reaction conditions and purification chromatograms. The release package contains the loading ratio measured by an orthogonal method (UV, ICP-MS or amino-acid analysis), identity by mass spectrometry where the conjugate permits it, and residual-free-payload data.
Service Highlights
- NIR fluorophore conjugation (IRDye, Cy5/Cy7 families) as the default route, with DOTA and NOTA chelator installation held as a proven fallback
- Photosensitizer coupling for photodynamic studies worked into the design where the application requires it
- Carrier and payload compatibility screened in a small feasibility batch before full material is committed
- Analytical confirmation of every intermediate before the final release
- Unreacted payload driven below the detection limit of the release assay before purification is closed
- Labeled peptide with dye-to-peptide ratio certificate delivered with a complete conjugation or synthesis certificate
How the work runs
Scope & design
We review the payload, the carrier and the intended assay or study, and propose between NIR fluorophore conjugation (IRDye, Cy5/Cy7 families) and DOTA and NOTA chelator installation as candidate routes.
Feasibility screen
A milligram-scale screen compares loading, residual payload and activity across the candidate conditions.
Production conjugation
The selected condition is executed at project scale with in-process sampling at fixed time points.
Purification
Size-exclusion, dialysis or magnetic separation removes free payload and by-products.
Characterization & release
Identity, loading ratio and functional activity are measured against the agreed specification.
Documentation & hand-off
Labeled peptide with dye-to-peptide ratio certificate is packaged with the full batch record, released for shipment after QC sign-off.
Specifications & timeline
- Turnaround
- 4–6 weeks
- Typical scale
- 0.1–50 mg conjugate per batch
- Chemistry options
- NIR fluorophore conjugation (IRDye, Cy5/Cy7 families); DOTA and NOTA chelator installation; photosensitizer coupling for photodynamic studies
- Deliverable
- Labeled peptide with dye-to-peptide ratio certificate
- QC package
- HPLC/SEC trace, MALDI-TOF or ESI-MS, UV/Vis or ICP-MS loading ratio
- Shipping
- Blue ice or dry ice as the payload requires, with a cold-chain manifest
Related Products
- Recombinant ProteinsGrowth factors, cytokines and antigens produced across E. coli, yeast, insect and mammalian hosts — over 10,000 items on the shelf and ready to move.
- Native ProteinsIsolated directly from natural sources, preserving native post-translational modifications and conformational epitopes that recombinant systems can miss.
- Monoclonal AntibodiesRecombinant and hybridoma clones characterised for Western blot, IHC, immunofluorescence, ELISA and flow cytometry — application data included.
Next step
Tell us the target, we will tell you what is feasible
Send the sequence, assay format and sensitivity you need. You will get a technical assessment — recommended platform, timeline and the risks worth knowing before you commit budget.